Solesence, Inc. Common Stock
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing…
1D
+1.3%
1W
-11.8%
1M
+2.3%
6M
-28.0%
YTD
-43.8%
1Y
-77.0%
2Y
-44.1%
5Y
-72.6%
10Y
+25.0%
Next earnings date
16/11/2026 (in 30 days)
Volatility around earnings
~34% stronger price swings than usual
P/E
-34.88
P/B
4.83
EV/EBITDA
916.52
RETURN ON EQUITY
-1.2%
NET MARGIN
-1.0%
DEBT/EQUITY
1.73
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
25.9%
FLOAT SHARES
18,331,837
AVG. DAILY VOLUME (30D)
29,849
Solesence, Inc. Common Stock is a company in the Consumer Defensive sector, Household & Personal Products industry, headquartered in United States.
The CEO is Kevin Cureton, the company employs around 115 people.
The IPO was on 26/11/1997; the stock trades on NASDAQ under the ticker SLSN.
The next earnings date is 16/11/2026.
Around past earnings, price swings were roughly 34% stronger than usual.
No, Solesence currently does not pay a dividend.
Comparable stocks include Procter & Gamble Company, Colgate-Palmolive Company, Estée Lauder Companies, Kenvue, Kimberly-Clark, Church & Dwight, Clorox Company and Coty.
Clicking "Analyze stock" lets five strategies assess Solesence against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.